Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
Pre-publication versions of this article are available by contacting email@example.com.
|12 Jun 2008||Submitted||Original manuscript|
|8 Jul 2008||Reviewed||Reviewer Report - John Souglakos|
|4 Aug 2008||Reviewed||Reviewer Report - Manfred Lutz|
|4 Dec 2008||Author responded||Author comments - Philippe Rougier|
|Resubmission - Version 2|
|4 Dec 2008||Submitted||Manuscript version 2|
|15 Dec 2008||Reviewed||Reviewer Report - John Souglakos|
|29 Dec 2008||Reviewed||Reviewer Report - Manfred Lutz|
|19 Mar 2009||Author responded||Author comments - Philippe Rougier|
|Resubmission - Version 3|
|19 Mar 2009||Submitted||Manuscript version 3|
|14 Apr 2009||Editorially accepted|
|14 Apr 2009||Article published||10.1186/1471-2407-9-112|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.